Axon Enterprise Inc.

▲ Bull Case

• ◆AI Era Plan is a re-rating event: Draft One grew 700% YoY in Q1 2026 with 1M+ hours of law enforcement body camera training data. An AI platform with 125% NRR should trade at 20–25x ARR (vs. 10–12x currently implied). If ARR reaches $2.5–3B by FY2028 at 20x, market cap approaches $50–60B or $595–714/share, closing the gap to analyst consensus.
• ◆$14.3B contracted backlog provides a 5-year revenue floor with zero incremental selling. No comparable growth company has this degree of forward revenue certainty. The backlog grew 43% YoY in FY2025. This ensures resilience to macro/government budget disruption and multi-year revenue growth even if new bookings slow.
• ◆SBC normalization is a mechanical tailwind: Rick Smith's PSU program has 5 tranches remaining, now behind the major triggers. If SBC falls from 22.8% to 18% of $4.15B FY2026 revenue, SBC drops ~$200M despite growth, flowing directly to GAAP FCF. Recovering from $75M to $400–500M by FY2027 would trigger major re-rating.

▼ Bear Case

• ◆SBC never normalizes; structural dilution permanently caps per-share value. AXON paid $634M in SBC in FY2025 (22.8% of revenue), with history of growth ($280M/'22, $350M/'23, $383M/'24). If SBC scales proportionally to $924M at $4.2B FY2026 revenue, per-share FCF growth erodes $11/share annually in dilution. History shows SBC tends to grow with revenue, not shrink — management's normalization guidance has been wrong before.
• ◆Government budget freeze creates structural booking pause. Trump administration has cut DOJ grants (BYRNE/JAG programs) that fund agency procurement. Axon-ACLU controversy creates friction in progressive cities (LA, Chicago, NYC). If FY2026 revenue comes in at $3.8B vs. $4.2B guided (9% miss), stock re-rates to $300–330/share. Management has never missed by more than 2%; a 9% miss would be thesis violation.
• ◆Carbyne integration disappoints on timeline and consumes bandwidth. Axon paid $625M (9–12x ARR multiple) and issued $1.75B Senior Notes, ending debt-free status. Carbyne's ~$300M FY2026 contribution is material to guidance. Slower migration to Axon 911, higher churn, or timeline delays miss the 47–51% growth guide. $100M annual interest expense creates fixed cost burden if growth slows.

“Central disagreement: Is SBC/FCF compression transient (resolves 2026–2027) or structural (permanent cost of AI talent war)? Bull camp (29 Buy/Strong Buy, PT $730) argues FY2025 FCF collapse ($330M→$75M) stems from temporary factors: Rick Smith PSU vesting (~$165M non-recurring) and Carbyne CapEx. Once normalized in FY2026–2027, GAAP FCF recovers to $400–600M+ and multiple re-rates to high-growth-SaaS premium, implying $595–714/share. AI Era Plan is additional re-rating lever not currently priced. Bear camp (5 Hold/Sell, PT $400–500) argues AXON is talent-intensive AI company in fierce competition for engineering talent, and SBC at 20%+ is structural. Employee SBC (~$450–470M non-PSU) has grown 5 consecutive years. FY2026 guidance is most aggressive in company history; depends on uncertain Carbyne and AI adoption curves. Miss would be first major execution failure, triggering outsized compression. Secondary debate: does $4.1–4.2B guidance represent sandbag (15 of 16 quarters beat) or overreach (Carbyne modeling)? Resolved by Q2 2026 earnings in July/August 2026.”

• ◆Q2 2026 Earnings (July/August 2026): First validation of FY2026 guidance trajectory; first look at SBC as % of revenue on normalization path; AI Era Plan ARR contribution quantified separately. Pass: Revenue ≥$960M (+35% YoY), SBC ≤20%, ARR ≥$1.65B. Beat + SBC improvement triggers multiple re-rate from distressed-FCF to growth-premium levels.
• ◆FY2026 ARR Exit Rate ≥$2.0B (February 2027): Q4 2026 ARR confirms AI Era Plan compounding ahead of model; triggers forward ARR multiple expansion. At $2.0B ARR × 20x = $40B+ equity value inflection point.
• ◆Federal Tier-1 Agency Contract (H2 2026–H1 2027): FBI, DHS, or DoD body camera or dispatch program announcement. Opens $10B+ federal TAM currently ignored by consensus; analogous to CRWD winning major government cloud contract.
• ◆Carbyne/Axon 911 First Live Major City Deployment (Q3–Q4 2026): First major metro (pop. ≥500K) live on Axon 911 dispatch with Evidence.com real-time integration. Validates full-stack public safety OS vision and de-risks integration execution.
• ◆AI Era Plan crossing $500M ARR (Q2–Q3 2027): Milestone makes Draft One/AI Era one of largest police-technology software products ever. Forces multiple expansion from EV/ARR framework toward EV/AI-ARR premium, closing valuation gap to Palantir/CrowdStrike comps.

• ◆SBC Structural Persistence (30% probability, HIGH impact): Employee SBC (~$470M of $634M) has grown every year for 5 consecutive years. If it scales with revenue rather than normalizes, per-share FCF growth is permanently eroded by $11/share annually in dilution.
• ◆FY2026 Guidance Miss ≥5% (25% probability, HIGH impact): Most ambitious guidance in company history. Carbyne contribution modeling and AI Era Plan adoption curve both carry significant estimation uncertainty. First major miss in 16-quarter run would trigger outsized multiple compression.
• ◆DOJ/Federal Grant Cuts + State Budget Stress (35% probability, MEDIUM impact): Trump administration actively cutting BYRNE/JAG grants that fund agency procurement. Axon-ACLU controversy creates political friction in progressive cities (LA, Chicago, NYC). Primarily affects 20% of AXON revenue but creates sentiment headwind.
• ◆AI in Policing Regulatory/Ethical Backlash (25% probability, HIGH impact): City councils and state legislatures considering restrictions on AI-generated police reports (Draft One), predictive analytics, biometric surveillance. Could require product modification or freeze adoption in politically progressive states.
• ◆Carbyne Integration Disappointment (20% probability, MEDIUM-HIGH impact): $625M acquisition with $1.75B in new debt; if 911 dispatch migration slower than modeled or Carbyne churn higher post-acquisition, FY2026 guidance and public safety OS narrative both impaired. New $100M annual interest creates fixed cost burden if growth slows.